Valeant Pharmaceuticals Intl Inc (VRX) to Release Earnings on Tuesday
Valeant Pharmaceuticals Intl Inc (TSE:VRX) (NYSE:VRX) will release its earnings data before the market opens on Tuesday, November 7th. Analysts expect Valeant Pharmaceuticals Intl to post earnings of C$1.19 per share for the quarter.
Shares of Valeant Pharmaceuticals Intl Inc (VRX) traded up 4.99% during midday trading on Tuesday, reaching $15.36. The company’s stock had a trading volume of 451,603 shares. The stock has a 50-day moving average of $16.83 and a 200 day moving average of $17.65. Valeant Pharmaceuticals Intl Inc has a 12-month low of $11.20 and a 12-month high of $32.50. The firm’s market capitalization is $5.35 billion.
A number of analysts have recently commented on the stock. Royal Bank Of Canada cut their target price on shares of Valeant Pharmaceuticals Intl to C$22.50 and set a “sector perform” rating for the company in a research note on Friday, October 20th. TD Securities increased their price target on shares of Valeant Pharmaceuticals Intl to C$26.00 and gave the company a “hold” rating in a research note on Wednesday, July 12th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of C$22.50.
About Valeant Pharmaceuticals Intl
Valeant Pharmaceuticals International, Inc is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices).
Receive News & Ratings for Valeant Pharmaceuticals Intl Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals Intl Inc and related companies with MarketBeat.com's FREE daily email newsletter.